Remnant cholesterol: "Non-(HDL-C + LDL-C)" as a coronary artery disease risk factor

Journal of the American College of Cardiology

Volumn 61, Issue 4, 2013, Pages 437-439

  McPherson, Ruth ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

coronary artery disease; lipoproteins; remnant cholesterol

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALLELE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CORONARY RISK; GENETIC ASSOCIATION; HUMAN; HYPERTRIGLYCERIDEMIA; NOTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84872682094     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.009     Document Type: Editorial

References (16)

1. A. Varbo, M. Benn, A. Tybjærg-Hansen, A.B. Jørgensen, R. Frikke-Schmidt, B.G. Nordestgaard Remnant cholesterol as a causal risk factor for ischemic heart disease J Am Coll Cardiol 61 2013 427 436
2. I.J. Goldberg, R.H. Eckel, R. McPherson Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol 31 2011 1716 1725
3. T. Pischon, C.J. Girman, F.M. Sacks, N. Rifai, M.J. Stampfer, E.B. Rimm Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men Circulation 112 2005 3375 3383
4. P.M. Ridker, N. Rifai, N.R. Cook, G. Bradwin, J.E. Buring Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women JAMA 294 2005 326 333
5. A.E. Di, N. Sarwar, P. Perry Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
6. S.M. Boekholdt, B.J. Arsenault, S. Mora Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis JAMA 307 2012 1302 1309
7. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
8. T.M. Teslovich, K. Musunuru, A.V. Smith Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
9. J.C. Cohen, E. Boerwinkle, T.H. Mosley, H.H. Hobbs Sequence variations in PCSK9, low LDL, and protection against coronary heart disease N Engl J Med 354 2006 1264 1272
10. D.A. Lawlor, R.M. Harbord, J.A. Sterne, N. Timpson, S.G. Davey Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med 27 2008 1133 1163
11. M. Orho-Melander, O. Melander, C. Guiducci A common missense variant in the glucokinase regulatory protein gene (GCKR) is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations Diabetes 57 2008 3112 3121
12. B.F. Voight, G.M. Peloso, M. Orho-Melander Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study Lancet 380 2012 572 580
13. D.M. Waterworth, S.L. Ricketts, K. Song Genetic variants influencing circulating lipid levels and risk of coronary artery disease Arterioscler Thromb Vasc Biol 30 2010 2264 2276
14. E.J. Schaefer, R.D. Santos, B.F. Asztalos Marked HDL deficiency and premature coronary heart disease Curr Opin Lipidol 21 2010 289 297
15. J.C. Mamo, S.D. Proctor, D. Smith Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma Atherosclerosis 141 Suppl 1998 S63 S69
16. D.B. Zilversmit A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins Circ Res 33 1973 633 638